TIGER NASDAQ BIOTIGER NASDAQ BIOTIGER NASDAQ BIO

TIGER NASDAQ BIO

Inga transaktioner
Se i superdiagram

Nyckeltal

Assets under management (AUM)
‪46.41 B‬KRW
Fund flows (1Y)
‪4.05 B‬KRW
Dividend yield (indicated)
0.13%
Discount/Premium to NAV
1.0%

Om TIGER NASDAQ BIO

Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Tiger ETF
Expense ratio
0.30%
Home page
Inception date
26 aug. 2014
Index tracked
NASDAQ Biotechnology Index
Management style
Passive
ISIN
KR7203780002

Classification

Asset Class
Equity
Kategori
Sektor
Focus
Sjukvård
Niche
Läkemedel, bioteknik och biovetenskap
Strategi
Börsspecifik
Weighting scheme
Börsvärde
Selection criteria
NASDAQ – noterade

Returns

1 månad3 månaderHittills i år1 år3 år5 år
Price performance
NAV total return

What's in the fund

As of 5 juni 2024
Exposure type
AktierBonds, Cash & Other
Hälsoteknik
Aktier97.98%
Hälsoteknik95.89%
Kommersiella tjänster1.74%
Hälsotjänster0.35%
Bonds, Cash & Other2.02%
Likvida medel2.02%
Stock breakdown by region
99%0%
Nordamerika99.95%
Europa0.05%
Latinamerika0.00%
Asien0.00%
Afrika0.00%
Mellanöstern0.00%
Oceanien0.00%
Top 10 holdings

Utdelningar

Utdelningshistorik

Assets under management (AUM)

Fund Flows